STAT
DECEMBER 16, 2023
Fidel Strub was 3 years old when his face began rotting away. “It’s hell. It’s like you have a burning face,” he told me. “You can’t even open your eyes because it’s just that bad. It’s just burning.” No one in his village in the West African country of Burkina Faso knew what was happening to him.
Drug Patent Watch
DECEMBER 16, 2023
VENTOLIN HFA (albuterol sulfate) Glaxosmithkline Patent: 7,832,351 Expiration: Dec 19, 2023 See More … For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com… The post Drug Patent Expirations for the Week of December 17, 2023 appeared first on DrugPatentWatch - Make Better Decisions.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
STAT
DECEMBER 16, 2023
STAT now publishes selected Letters to the Editor received in response to First Opinion essays to encourage robust, good-faith discussion about difficult issues. Submit a Letter to the Editor here , or find the submission form at the end of any First Opinion essay. “ U.S. medical schools aren’t teaching future doctors about 7.
Drug Patent Watch
DECEMBER 16, 2023
Icosapent ethyl is the generic ingredient in two branded drugs marketed by Apotex, Dr Reddys, Hikma, Strides Pharma, Teva Pharms Usa, Zydus, and Amarin Pharms and, and is included in… The post New tentative approval for Ascent Pharms drug icosapent ethyl appeared first on DrugPatentWatch - Make Better Decisions.
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
The Honest Apothecary
DECEMBER 16, 2023
The 5 members of the hospital management team sat somewhat nervously around the conference room table. They had done their homework, gathered their metrics, and printed their reports. This was the first “official” meeting with their new boss and they wanted to start off on the right foot. The new leader walked in right at 10:00am sharp. She wore a long sleeved, light gray pant suit, a brown belt and a white blouse.
Drug Patent Watch
DECEMBER 16, 2023
Dasatinib is the generic ingredient in two branded drugs marketed by Apotex and Bristol Myers Squibb and is included in three NDAs. There are two patents protecting this compound. Drug… The post New tentative approval for Teva Pharms drug dasatinib appeared first on DrugPatentWatch - Make Better Decisions.
Pharmacist Digest brings together the best content for pharmacists from the widest variety of industry thought leaders.
Welltopia Pharmacy
DECEMBER 16, 2023
Heart-Healthy Living: Unlocking the Power of Omega-3s with WellPure Omega 1300 EC® Introduction Heart-healthy living is a cornerstone of
Drug Patent Watch
DECEMBER 16, 2023
This chart shows the pharmaceutical companies with the most patents in Netherlands. Patents must be filed in each country (or, in some cases regional patent office) where patent protection is… The post Which pharmaceutical companies have the most drug patents in Netherlands? appeared first on DrugPatentWatch - Make Better Decisions.
RX Note
DECEMBER 16, 2023
Introduction Medication error is any preventable event that may harm patient. In outpatient pharmacy setting, CQDC (centralised quality dispensing control) is ideally in place to minimise medication errors. Most medications errors can be attributed to carelessness or fatigue, such as Picking up the wrong medications or medications with wrong strength Labelling error on dose and frequency Labelling error on patient name Since all humans make mistakes , focusing on improving weaknesses in the medi
Expert insights. Personalized for you.
303 
Let's personalize your content